Type 2 diabetes
PMA-stimulated PC-1 in patients with Type 2 diabetes was 17-times higher than in        controls, and was reduced to near the control level by 3-month metformin       treatment.
PMA-stimulated PC-1 in  @OBJECT$   @PREDICAT$   @SUBJECT$  was 17-times higher than in        controls, and was reduced to near the control level by 3-month metformin       treatment.